Last $4.07 USD
Change Today -0.04 / -0.97%
Volume 38.9K
TRXC On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

transenterix inc (TRXC) Snapshot

Open
$4.07
Previous Close
$4.11
Day High
$4.12
Day Low
$3.93
52 Week High
04/2/14 - $14.00
52 Week Low
05/20/14 - $2.81
Market Cap
256.3M
Average Volume 10 Days
66.0K
EPS TTM
$-2.07
Shares Outstanding
63.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TRANSENTERIX INC (TRXC)

Related News

No related news articles were found.

transenterix inc (TRXC) Related Businessweek News

No Related Businessweek News Found

transenterix inc (TRXC) Details

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of a robotic assisted surgical system in the United States. The company is primarily developing SurgiBot system, a reduced incision, patient-side robotic assisted surgery system. It also offers SPIDER surgical system, which accommodates a range of flexible instruments through articulating instrument delivery tubes; and working channels that enable the use of rigid instruments. In addition, the company develops and manufactures flexible and rigid laparoscopic surgical instruments, such as scissors, graspers, clip appliers, and suction and irrigation instruments that are used in abdominal surgery with the SPIDER system. TransEnterix, Inc. is based in Morrisville, North Carolina.

91 Employees
Last Reported Date: 03/5/14

transenterix inc (TRXC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $325.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $94.1K
Chief Operating Officer
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2013.

transenterix inc (TRXC) Key Developments

TransEnterix, Inc. Announces Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

TransEnterix, Inc. announced consolidated unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported sales of $113,000 against $521,000 a year ago. The decrease in revenue was due to lower sales volumes of the SPIDER Surgical System as a result of the reduction in its U.S. sales force headcount. Operating loss was $10,381,000 against $4,052,000 a year ago. Net loss was $10,587,000 against $4,285,000 a year ago. Net loss per basic and diluted share was $0.18 against $3.97 a year ago. For the six months, the company reported sales of $206,000 against $850,000 a year ago. Operating loss was $17,539,000 against $8,573,000 a year ago. Net loss was $18,066,000 against $9,062,000 a year ago. Net loss per basic and diluted share was $0.33 against $8.41 a year ago. Net cash and cash equivalents used in operating activities was $13,362,000 against $7,443,000 a year ago. Purchase of property and equipment was $910,000 against $150,000 a year ago.

TransEnterix, Inc., Q2 2014 Earnings Call, Aug 06, 2014

TransEnterix, Inc., Q2 2014 Earnings Call, Aug 06, 2014

TransEnterix, Inc. to Report Q2, 2014 Results on Aug 06, 2014

TransEnterix, Inc. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRXC:US $4.07 USD -0.04

TRXC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Covidien PLC $88.79 USD +0.35
Intuitive Surgical Inc $467.50 USD -5.67
Johnson & Johnson $103.21 USD +0.25
Stryker Corp $81.89 USD -0.09
View Industry Companies
 

Industry Analysis

TRXC

Industry Average

Valuation TRXC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 311.6x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 253.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRANSENTERIX INC, please visit www.transenterix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.